Literature DB >> 17137639

Voice therapy in pediatric functional dysphonia: a prospective study.

Margherita Trani1, Angelo Ghidini, Giuseppe Bergamini, Livio Presutti.   

Abstract

OBJECTIVE: We evaluated the efficacy of voice therapy according to Borragan's method associated to S. Magnani's vocal counselling in functional dysphonia in children. PATIENTS AND METHODS: We prospectively treated 16 patients with vocal fold nodules (10 males, 6 females). Age ranged from 6 to 11 years with a mean age of 9 years. We performed a full screening phoniatric evaluation. In addition psychological tests were carried out to investigate psychological background.
RESULTS: We lost three patients at follow-up; one patient received surgery, eight patients healed (43.75%), four improved (25%). There was no statistical difference in the analysis of electroacoustical parameters while MPT significatively raised after therapy.
CONCLUSION: If patients have motivation voice therapy could improve functional dysphonia in children. It is also important psychological background. Further studies on bigger populations with long-term follow-up are needed.

Entities:  

Mesh:

Year:  2006        PMID: 17137639     DOI: 10.1016/j.ijporl.2006.11.002

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  Relative Fundamental Frequency in Children With and Without Vocal Fold Nodules.

Authors:  Elizabeth S Heller Murray; Roxanne K Segina; Geralyn Harvey Woodnorth; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2020-02-14       Impact factor: 2.297

Review 2.  Impact of Voice Therapy on Pediatric Patients With Dysphonia and Vocal Nodules: A Systematic Review.

Authors:  Mohammad Al-Kadi; Mohamed A Alfawaz; Fahad Z Alotaibi
Journal:  Cureus       Date:  2022-04-24

3.  Describing pediatric dysphonia with nonlinear dynamic parameters.

Authors:  Morgan L Meredith; Shannon M Theis; J Scott McMurray; Yu Zhang; Jack J Jiang
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-10-22       Impact factor: 1.675

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.